Raise the Line

One silver lining of the COVID-19 pandemic is a jump in enrollments in public health degree programs and that’s welcome news to Dr. Jan Carney, director of the Master of Public Health program at the University of Vermont's Larner College of Medicine, who believes the field needs a massive injection of personnel. “We need probably an 80% increase in people working in state and local health departments to have the essentials of public health.” As Vermont’s former Commissioner of Health, Carney knows the challenges public health officials face and brings those insights to Larner’s online-only MPH program, which covers the broad domains of the field from epidemiology to biostatistics to environmental health and also exposes students to the particular health challenges in rural communities. The program also prepares students for perhaps the biggest challenge facing the field: communication of health information in an era of misinformation.  To that end, Carney is urging more ascertainment of how different groups of people prefer to receive information and is suggesting a major change in approach. “Maybe we can start to think of public health communication more as a conversation than a one-way information flow.” Join host Michael Carrese for insights from a national force in public health into how education is evolving to prepare public health practitioners for their vital work in challenging times for the profession.Mentioned in this episode: https://www.uvm.edu/publichealth/ If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Raise the Line’s in-depth look at the potential use of psychedelic compounds in mental health treatment continues today with a focus on the role they may play in helping people overcome substance use disorders. Our guest is Dr. Jeeshan Chowdhury, whose own mental health journey led him to found Journey Colab, a company combating addiction through psychedelic care while employing a unique stakeholder model that includes indigenous communities in ownership. “We have put 10% of the founding equity of the company into an irrevocable purpose trust so that the land, the traditions and the people that our medicines and our work are inspired from can benefit from it,” explains Chowdhury. He tells host Shiv Gaglani that indigenous traditions also inform how the company approaches psychedelic therapy itself. “When we look at their use, it is always done in the context of an expert healer, often called a shaman, and it's done as part of a very well-honed protocol and in the context of a larger community.” Check out this thoughtful discussion to find out why Chowdhury thinks of the therapeutic use of psychedelics as akin to surgery, and how Journey Colab is working with rehab center partners to integrate psychedelic care through clinical trials with the goal of creating an integrated treatment program.Mentioned in this episode: https://www.journeycolab.com If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Today’s episode touches on some regular themes we explore on Raise the Line such as equal access to quality healthcare, provider burnout and the impact of AI on medicine, but on this episode, we have the welcome opportunity to take a look at these key issues from the perspective of a doctor-turned-entrepreneur in Brazil. Today, Dr. Bruno Lagoeiro is an executive at Afya, one of the largest medical education groups in Brazil, but he started out as a med student who was interested in solving problems he and his classmates were encountering. After years of experimentation, and guidance from a business mentor, the solution they developed was Whitebook, a mobile app for clinical decision-support that’s used in tens of millions of patient encounters every year in Brazil. Join host Shiv Gaglani as he draws out the details of Dr. Lagoeiro’s amazing journey to improve healthcare in a huge and diverse country that faces delivery challenges in poor and remote communities and a provider workforce being drained by bureaucracy. Despite these hurdles, Dr. Lagoeiro has an optimistic message to share about the power of providers to change healthcare and the promise of AI to allow them to focus more on the human aspects of medicine. Mentioned in this episode: Afya If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Dr. Lewis Nasr, a research fellow at MD Anderson Cancer Center, discusses the challenges of learning in difficult circumstances and his interest in hematology-oncology. He also talks about the growth of Osmosis, the Year of the Zebra project, and plans for the internal medicine residency match.

Today’s Raise the Line guest, Dr. Megan Meyer, has a pretty simple message for proponents of  psychedelic-assisted therapy (PAT) who are concerned that demand for therapists will outstrip supply in the coming years: don’t overlook the largest group of mental health providers in the nation. “Social workers provide more mental health services than psychologists, psychiatrists and psychiatric nurses combined and we’re embedded everywhere. I don't think the psychedelic renaissance can actually achieve its aims without us,” says Meyer, who is an associate professor at the University of Maryland School of Social Work. Meyers adds that social workers also happened to be well-equipped for PAT because they’re trained to act as guides in helping clients find their own voice and not impose their own perspectives or biases.  Getting large numbers trained will require collaboration across disciplines, universities and training institutes such as the project she’s working on with colleagues at the university’s Schools of Pharmacy and Nursing to survey social workers and nurses regarding their current knowledge and training needs related to psychedelics. Join host Michael Carrese for an expansive conversation about the role social workers can play in minimizing the risks and realizing the potential of psychedelics including issues of bias and diversity, community-based models of post-therapy integration and learning from the practices of indigenous societies.Mentioned in this episode: https://www.ssw.umaryland.edu/ If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

There's a relatively small number of people who have had the opportunity to create a medical school from the ground up, which is why today’s Raise the Line guest, Dr. Robert Hasty, is particularly interesting to talk to because he’s had that chance three times. Currently, he is involved in launching one of the nation's newest medical schools, the Orlando College of Osteopathic Medicine, in one of its fastest growing areas, Central Florida. “I think one of the things I've learned is that everything is incredibly connected at a medical school -- the facility, the curriculum, the culture, the clinical rotation partners...it all has to work together, so that's one of the things that we've done.” Hasty and his team have also designed a modern curriculum that’s taking a “lecture-less,” team-based, case-based, systems-based approach that interweaves clinical skills and knowledge of basic science throughout the four years. And on top of all that, given the school’s proximity to Disney World, you can see fireworks every night from campus! Join host Shiv Gaglani for this hopeful look at the cutting-edge of medical education.  Mentioned in this episode: https://ocom.org/ If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

If you get nothing else from listening to this memorable episode of Raise the Line, you’ll at least have the chance to do a breathing exercise in real time along with host Shiv Gaglani and his guest, Dr. Michelle Thompson, who is triple board certified in lifestyle, integrative, and osteopathic family medicine. Dr. Thompson has come to rely on a breathing practice for her own daily wellbeing and offers to do it along with all of her patients as well as countless medical students, residents and colleagues. In fact, as a strong advocate for provider wellness, she's created full-day programs for physicians and nurses to learn tools like breathwork for resilience and self-care. “Self-care is not selfish. If we are caring for ourselves, we are more available to others,” she explains. In addition to her role as medical director of the Lifestyle Medicine Institute at the University of Pittsburgh Medical Center, Thompson is a national force in establishing lifestyle medicine programs in health systems across the country, as nearly 100 organizations have done.  Taking it a step further, UPMC is building a new hospital in the city that Thompson says is going to have a “lifestyle village” on the first three floors to facilitate the efforts of community members to choose healthy habits. Join us as we explore the impact lifestyle and mind-body medicine is having on patient care, employee wellness and medical education in Pittsburgh and far beyond in this perspective-shifting conversation.Mentioned in this episode: University of Pittsburgh Medical Center If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Today’s Raise the Line guest has created two new degree programs at Brown University, is a vice president and board director at one of the oldest venture capital firms in the nation, and was CEO at a groundbreaking digital healthcare company. Oh, and he’s still in his twenties.  As an investor, Morgan Cheatham -- who is also a third-year medical student at Brown University -- is applying his impressive experience, intellect and energy to the use of computation in improving patient care, and he’s encouraged by what he sees. A prime example is Abridge, a company that uses an AI audio system to capture and summarize the information patients share during appointments, allowing the doctor to focus on the patient, not on typing notes.  “A guiding light in my career has been how we take this sacred one-to-one relationship and scale it one to many, and Abridge is the company that does just that,” Cheatham tells host Shiv Gaglani, who also happens to be a successful healthcare entrepreneur and third-year medical student.  And while Cheatham is excited by the potential application of AI in healthcare, he notes that the medical community needs to move quicky to establish quality standards for its use. “How do we build the right validation benchmarks and evaluation criteria to know whether or not it is performing well?” Don’t miss this fun and fascinating conversation that also covers the necessity of embracing ambiguity, remaining curious and seeking diverse perspectives to navigate the rapidly evolving landscape of healthcare and technology. Mentioned in this episode: Bessemer Venture Partners  If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

As researchers continue to explore therapeutic applications of existing psychedelic drugs such as LSD and psilocybin, there's been a parallel effort to create new compounds that produce the same beneficial effects, but that come without the lengthy protocols and regulatory obstacles attached to those currently criminalized substances. "If you could develop new molecules that were more targeted and shorter acting, you may actually be able to create medicines as potent as the existing ones, but administratively and medically more efficient so we can reach more people," says Ronan Levy, a serial entrepreneur in the space. After a foray into creating a business model for ketamine-assisted therapy, Levy is now looking to support the community of millions of people who are already using psychedelics in various capacities through his Non-Ordinary Therapy Company instead of providing the therapeutic experience directly. “Wherever you're having your psychedelic experiences, that's wonderful. We're there to help you get the maximum impact from your sessions.” Join host Shiv Gaglani for this fascinating conversation about responsibly pushing regulatory boundaries, whether hallucinatory effects are essential to therapeutic benefit, and the rapid pace of change in a field that holds the potential to, as Levy puts it, “displace most forms of mental health care currently provided.” Mentioned in this episode: Non-Ordinary Therapy CompanyThe Ketamine Breakthrough (book) If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Distance learning continues to grow in popularity with most college students in the U.S. now taking at least some classes online offered by hundreds of brick-and-mortar and exclusively online institutions. We’re going to learn about one of the highest ranked programs in the space today with Geordie Hyland, president and CEO of the American College of Education. One way ACE sets itself apart in a crowded field is that 85% of its students graduate with no debt, which Hyland says is reflective of the school’s mission. “ACE was founded with a key consideration about return on the students' time and financial investment so we have some of the lowest tuition in the nation, but we also provide a fully online, high-quality experience.” Check out this informative conversation with host Derek Apanovitch to learn about ACE’s programs that are tailored to address pressing staffing shortages in healthcare, its data-driven approach to student support, and the collaborative interactions it facilitates among its 10,000 students. "It's fascinating to see students from very different geographic regions be able to share ideas and collaborate," says Hyland.Mentioned in this episode: https://ace.edu/ If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast